Growth Metrics

Lexicon Pharmaceuticals (LXRX) Prepaid Assets (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) reported Prepaid Assets of $3.3 million for Q1 2026, little changed year-over-year from $3.3 million in Q1 2025, and up 10.63% on a QoQ basis from $3.0 million in Q4 2025.

Lexicon Pharmaceuticals (LXRX) has 17 years of Prepaid Assets data on file, last reported at $3.3 million in Q1 2026.

  • Quarterly Prepaid Assets changed 0.0% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (changed 0.0% YoY) and the FY2025 annual result came in at $3.0 million, down 33.8% from the prior year.
  • Prepaid Assets climbed to $3.3 million in Q1 2026 per LXRX's latest filing, from $3.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.7 million in Q2 2024 and bottomed at $1.9 million in Q1 2022.
  • The 5-year median for Prepaid Assets is $3.7 million (2025), against an average of $4.3 million.
  • The widest annual swing landed in 2023, when Prepaid Assets soared 111.46%; it then sank 52.65% in 2025.
  • Tracing LXRX's Prepaid Assets over 5 years: stood at $2.5 million in 2022, then surged by 106.77% to $5.1 million in 2023, then fell by 11.66% to $4.5 million in 2024, then slumped by 33.8% to $3.0 million in 2025, then grew by 10.63% to $3.3 million in 2026.
  • Per Business Quant, the three latest LXRX Prepaid Assets figures stand at $3.3 million (Q1 2026), $3.0 million (Q4 2025), and $4.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Lexicon Pharmaceuticals 872.52 Mn 701.87 Mn 20.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.32 Mn
Dec 31, 2025 3.00 Mn
Sep 30, 2025 4.09 Mn
Jun 30, 2025 3.73 Mn
Mar 31, 2025 3.32 Mn
Dec 31, 2024 4.53 Mn
Sep 30, 2024 6.71 Mn
Jun 30, 2024 7.68 Mn
Mar 31, 2024 7.01 Mn
Dec 31, 2023 5.13 Mn
Sep 30, 2023 4.29 Mn
Jun 30, 2023 6.12 Mn
Mar 31, 2023 3.35 Mn
Dec 31, 2022 2.48 Mn
Sep 30, 2022 2.82 Mn
Jun 30, 2022 2.90 Mn
Mar 31, 2022 1.89 Mn
Dec 31, 2021 2.16 Mn
Sep 30, 2021 3.06 Mn
Jun 30, 2021 4.60 Mn
Mar 31, 2021 3.95 Mn
Dec 31, 2020 5.05 Mn
Sep 30, 2020 9.11 Mn
Jun 30, 2020 9.46 Mn
Mar 31, 2020 8.20 Mn
Dec 31, 2019 5.32 Mn
Sep 30, 2019 5.97 Mn
Jun 30, 2019 6.63 Mn
Mar 31, 2019 4.69 Mn
Dec 31, 2018 2.67 Mn
Sep 30, 2018 3.40 Mn
Jun 30, 2018 3.95 Mn
Mar 31, 2018 4.28 Mn
Dec 31, 2017 4.43 Mn
Sep 30, 2017 4.46 Mn
Jun 30, 2017 10.17 Mn
Mar 31, 2017 10.38 Mn
Dec 31, 2016 3.88 Mn
Sep 30, 2016 2.44 Mn
Jun 30, 2016 9.07 Mn
Mar 31, 2016 14.27 Mn
Dec 31, 2015 10.14 Mn
Sep 30, 2015 10.95 Mn
Jun 30, 2015 7.15 Mn
Mar 31, 2015 3.19 Mn
Dec 31, 2014 4.76 Mn
Sep 30, 2014 5.94 Mn
Jun 30, 2014 7.34 Mn
Mar 31, 2014 6.57 Mn
Dec 31, 2013 4.64 Mn
Sep 30, 2013 7.26 Mn
Jun 30, 2013 6.68 Mn
Mar 31, 2013 8.44 Mn
Dec 31, 2012 6.35 Mn
Sep 30, 2012 9.00 Mn
Jun 30, 2012 6.58 Mn
Mar 31, 2012 5.14 Mn
Dec 31, 2011 3.75 Mn
Sep 30, 2011 4.34 Mn
Jun 30, 2011 3.87 Mn
Dec 31, 2010 2.88 Mn